Ivermectin for Scabies: Dosing and Management
For typical scabies, treat with oral ivermectin 200 mcg/kg as two doses separated by 2 weeks, while crusted scabies requires combination therapy with both oral ivermectin (200 mcg/kg on days 1,2,8,9, and 15) plus daily topical permethrin 5% for 7 days then twice weekly until cure. 1
Typical (Uncomplicated) Scabies
Dosing Regimen
- Ivermectin 200 mcg/kg orally, repeated in 2 weeks 1
- Take on an empty stomach with water to maximize bioavailability 1, 2
- The second dose is critical because ivermectin has limited ovicidal activity and does not kill all life cycle stages of the parasite 1
Important caveat: Recent research demonstrates that single-dose regimens fail in 42% of cases, while two-dose regimens achieve 98% cure rates 3. The absence of a second dose is the main predictor of treatment failure (P < 0.001) 3.
Alternative: Permethrin First-Line
While ivermectin is effective, permethrin 5% cream remains the preferred first-line treatment as it is more effective, safer, and less expensive than ivermectin 1. Apply to entire body from neck down, wash off after 8-14 hours 1.
Crusted (Norwegian) Scabies
High-Risk Populations
Occurs in immunocompromised patients including:
- HIV/AIDS patients
- Organ transplant recipients
- Those on systemic corticosteroids
- Patients with hematologic malignancies
- Malnourished or debilitated persons 1
Combination Therapy Required
Single-agent therapy fails substantially in crusted scabies 1. The recommended approach is:
Oral ivermectin:
- 200 mcg/kg on days 1,2,8,9, and 15 1
- Additional doses on days 22 and 29 may be required for severe cases 1
PLUS topical therapy:
- Permethrin 5% cream OR benzyl benzoate 5%
- Apply daily for 7 days, then twice weekly until cure 1
This aggressive regimen is necessary because topical agents cannot penetrate the thick, scaly skin that harbors massive mite burdens 1.
Contraindications and Special Populations
Absolute Contraindications
- Children weighing <15 kg: Safety not established 1
- Severe liver disease: Safety of multiple doses unknown 1
Relative Contraindications (Use Permethrin Instead)
Pregnant women:
- Ivermectin likely poses low risk but has limited safety data 1
- Permethrin is the preferred treatment 1
Lactating women:
Infants and young children:
- Use permethrin for children <15 kg 1
HIV-Positive Patients
- Uncomplicated scabies: Same treatment as HIV-negative patients 1
- Higher risk for crusted scabies: Manage in consultation with specialist 1
Common Pitfalls and How to Avoid Them
Treatment Failure Causes
- Missing the second dose - Most common cause of failure 3
- Improper topical application - Must cover entire body from neck down 1
- Failure to treat contacts - Treat all household and sexual contacts from preceding month 1
- Incomplete decontamination - Machine wash/dry bedding and clothing on hot cycle or remove from body contact for 72 hours 1
- No written instructions - Provide clear documentation 4
Post-Treatment Expectations
- Pruritus and rash may persist up to 2 weeks after successful treatment 1
- This is due to allergic dermatitis, not treatment failure 1
- Consider retreatment only if symptoms persist >2 weeks OR live mites observed 1
- New eczematous eruptions within 72 hours of ivermectin are a recognized adverse event requiring topical corticosteroids 5
When to Retreat
- Symptoms persisting >2 weeks 1
- Live mites observed on follow-up 1
- Consider alternative regimen if initial treatment fails 1
Institutional Outbreaks
For nursing homes, hospitals, or residential facilities:
- Treat entire population at risk simultaneously 1
- Ivermectin particularly useful when topical scabicides fail 1
- Manage in consultation with specialist 1
Emerging Resistance Concerns
While direct proof of permethrin resistance is lacking, there is a rising number of well-documented cases of poor response 4. This has led to increased use of ivermectin as first-line therapy in some settings, though permethrin remains guideline-recommended first-line treatment 1.